Abstract
Background: Despite being readily available in the clinical setting and prevalent usage of diagnostic and prognostic gene expression profiles (GEP) for the management of melanoma, no recommendations exist to direct their integration into clinical practice. To meet this need, a set of expert-derived, consensus-based appropriate use criteria (AUC) recommendations for the usage of GEP profiling technology in the diagnosis and management of melanoma in specifically-defined situations commonly encountered by the practicing dermatologist was developed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
